Global Blood Therapeutics Announces Publication of Preclinical Results Supporting GBT440 Program for Hypoxemic Pulmonary Disorders

SOUTH SAN FRANCISCO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with significant unmet need, today announced publication of preclinical data supporting the development of GBT440 for the treatment of hypoxemic pulmonary disorders, including idiopathic pulmonary fibrosis (IPF), in Physiological Reports. To date, GBT has established preclinical proof of concept for GBT1118, a hemoglobin modifier and analog of GBT440, in three different animal models of hypoxia. Data from these models support the potential beneficial effects of hemoglobin modification as a promising therapeutic strategy

Immune Design Announces Proposed Public Offering of Common Stock

SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Immune Design Corp. (Nasdaq:IMDZ) announced today that it plans to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the proposed offering are to be sold by Immune Design. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. Jefferies LLC, Leerink Partners LLC and Wells Fargo Securities, LLC are acting as joint book-running managers for the

New Study Reveals Customer Experience is Getting Worse; Contact Centers Out of Touch with the Reality of Today’s Consumer

BOSTON, Sept. 14, 2016 (GLOBE NEWSWIRE) — A new study from BoldChat by LogMeIn (Nasdaq:LOGM) and Ovum reveals that customer experience has worsened over the last two years despite investments in new engagement channels.  The report, which surveyed hundreds of contact center managers and consumers globally, found that the consumers surveyed believe it takes 6 different interactions to resolve an issue while the surveyed contact center managers believe it takes only 1-2 touchpoints.  This disconnect can be largely due to the fact that 72% of consumers surveyed search for information online before contacting an agent but the majority of contact center

INC Research and CISCRP Announce Finalists for “Inspiring Hope” Ideathon

RALEIGH, N.C., Sept. 14, 2016 (GLOBE NEWSWIRE) — INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, together with the Center for Information and Study on Clinical Research Participation (CISCRP), a non-profit organization dedicated to engaging the public and patients as partners in the clinical research process, today announced the finalists for the “Inspiring Hope” Ideathon event. In a competition that inspired nearly 70 entries, 14 ideas submitted by teams from around the world have been shortlisted for their potential to help address the critical need to increase awareness of clinical trial participation among

Low Smoke Halogen Free Flame Retardant PP Market Worth $893.9 Million By 2024: Grand View Research, Inc.

San Francisco, Sept. 14, 2016 (GLOBE NEWSWIRE) — The global low smoke halogen free flame retardant polypropylene (PP) market is expected to reach USD 893.9 million by 2024, according to a new report by Grand View Research, Inc. The increasing construction spending particularly in emerging economies is one of the major reason fueling the market growth. Favorable government regulations are further anticipated to benefit the overall market. The government bodies across the globe have been formulating new regulations and safety norms to reduce the occurrence of fire mishaps. Halogen-free flame retardant polypropylene is believed to be an effective way to overcome

Epoxy Resin Market Projected To Reach $14.26 Billion By 2024: Grand View Research, Inc.

San Francisco, Sept. 14, 2016 (GLOBE NEWSWIRE) — The global epoxy resin market is expected to reach USD 14.26 billion by 2024, according to a new report by Grand View Research, Inc. The market is anticipated to be driven by end-use industries including automotive, aerospace, transportation, composites, decorative coatings, construction, industrial & marine coatings, electrical & electronics, especially in Asia Pacific. Epoxy resins are the most preferred thermoplastics for manufacturing composite materials owing to their superior properties as compared to other materials. Huge production capacities of epichlorohydrin and bisphenol A, especially in China, ensure consistent raw material supply. However, fluctuating raw

Xenon Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Closing of $34.5 Million Public Offering

BURNABY, British Columbia, Sept. 13, 2016 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that the underwriters of the previously announced public offering of its common shares have exercised in full their option to purchase an additional 600,000 common shares, consisting of 450,000 common shares from Xenon and 150,000 common shares from the selling securityholders named in the final prospectus supplement for the offering. The closing of the sale of all common shares occurred today. Gross proceeds from the offering of an aggregate of 3,450,000 common shares by Xenon and the offering of an aggregate of

Golden Gate University School of Law Celebrates Permanent Overtime Rights for California Domestic Workers

SAN FRANCISCO, Sept. 13, 2016 (GLOBE NEWSWIRE) — Governor Edmund G. Brown, Jr. yesterday signed SB 1015, a bill making overtime rights permanent for more than 300,000 nannies and caregivers for seniors and people with disabilities. Golden Gate University School of Law’s Women’s Employment Rights Clinic (WERC) has served as legal counsel to the California Domestic Workers Coalition since 2010 in the Coalition’s effort to extend basic wage and hour protections to domestic workers.  In 2013, Governor Brown signed AB 241, sponsored by the Coalition, extending for the first time overtime rights to domestic workers; the bill was set to

City National Opens Banking Office in Lower Manhattan

NEW YORK, Sept. 13, 2016 (GLOBE NEWSWIRE) — City National Bank, America’s Premier Private and Business BankSM, announced today that it has opened its third full-service banking office in Manhattan at Brookfield Place. The office is located on the 26th floor of 250 Vesey St., formerly known as Four World Financial Center, between the Hudson River and the rebuilt World Trade Center, in the heart of Lower Manhattan. The new office will provide City National’s premier private and business banking and wealth management capabilities to financial services employees, small and mid-sized businesses, nonprofit organizations, professionals, investors, and other individuals and

Pentaho Announces 2016 Excellence Award Winners

SAN FRANCISCO and ORLANDO, Fla., Sept. 13, 2016 (GLOBE NEWSWIRE) — Pentaho, a Hitachi Group Company, today announced the 2016 Excellence Award winners. The awards recognize the Pentaho customers responsible for the year’s most innovative and impactful implementations of Pentaho technology. Pentaho customers from around the world submitted their nominations in one of six categories, where the contest judges evaluated the submissions based on the creativity, impact and business value of the Pentaho deployment. This year’s judges’ panel included: Howard Dresner, Chief Research Officer, Dresner Advisory Services Greg Knieriemen, Technology Evangelist, Hitachi Data Systems Rosanne Saccone, Chief Marketing Officer, Pentaho,

Molecular Diagnostics Market To Reach $17.9 Billion By 2024: Grand View Research, Inc.

San Francisco, Sept. 13, 2016 (GLOBE NEWSWIRE) — Global molecular diagnostics market is expected to reach over USD 17.9 billion by 2024, based on a new report by Grand View Research, Inc. Increasing prevalence of infectious diseases including human papillomavirus and influenza is expected to be the primary driving force for the growth of the molecular diagnostics market. In the underdeveloped regions of Africa and Nigeria, other infections, such as HIV and tuberculosis, are soaring at a high growth rate since the last few years. This is estimated to increase the demand for early and accurate diagnostic techniques to curb their

North America Fragrance Wax Melts Market Worth $2.90 Billion By 2024: Grand View Research, Inc.

San Francisco,, Sept. 13, 2016 (GLOBE NEWSWIRE) — North America fragrance wax melts market is expected to reach USD 2.90 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand for home fragrance products coupled with rising significance of aromatherapy will augment product consumption over the forecast period. The absence of exposed flames and harmful emissions, makes wax melts a safe and eco-friendly option which will drive its demand over the forecast period. Fragrance wax melts are expected to witness strong growth over the upcoming years on account of increasing demand for air care. Growing consumer

North America Awnings Market To Reach $3.64 Billion By 2024: Grand View Research, Inc.

San Francisco,, Sept. 13, 2016 (GLOBE NEWSWIRE) — North America awnings market is expected to reach USD 3.64 billion by 2024, according to a new report by Grand View Research, Inc. High level of customization coupled with rising application scope in residential and commercial sectors is expected to propel growth. Furthermore, rising penetration of motorized retractable products in the residential sector is expected to augment demand over the forecast period. The industry is characterized by a large number of local manufacturers and distributors owing to the region-specific products. Fabric awnings are primarily used in tropical areas owing to its high aesthetic

Solar Control Glass Market To Reach $8.88 Billion By 2024: Grand View Research, Inc.

San Francisco, Sept. 12, 2016 (GLOBE NEWSWIRE) — The global solar control glass market is expected to reach USD 8.88 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand owing to positive construction and automotive industry outlook is expected to propel solar control glass market growth. Solar control glass allows a significant amount of sunlight to pass through and reflects a large amount of solar heat thus making it suitable for green building applications. The growing trend of green buildings constructions with high energy efficiency and reduced CO2 emissions is expected to drive market demand

Neurostimulation Devices Market Worth $9.8 Billion By 2024: Grand View Research, Inc.

San Francisco, Sept. 12, 2016 (GLOBE NEWSWIRE) — The neurostimulation devices market is expected to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. The neurostimulation devices market is anticipated to witness a significant growth during the study period from 2016 to 2024. This growth is majorly attributed to high prevalence of chronic diseases, including migraine and epilepsy. Increasing adoption of unhealthy lifestyle, diet, and growth in aging population is resulting in a growing incidence of the chronic disease in individuals. However, adverse effects and risks associated with neurostimulation devices and presence of stringent

China Antiscalant market To Reach $555.6 Million By 2024: Grand View Research, Inc.

San Francisco, Sept. 12, 2016 (GLOBE NEWSWIRE) — The China antiscalant market is expected to reach USD 555.6 million by 2024, according to a new report by Grand View Research, Inc. Antiscalants are used in applications where water with heavy metals comes in contact with surfaces causing scales, thereby, reducing the overall efficiency of the equipment and damaging the manufactured goods. The increasing use of antiscalants in coal gasification, power generation, and chemical plants to maintain efficient functioning of machinery will fuel industry expansion. Moreover, development of these end-use sectors on account of rapid industrialization and urbanization is expected to contribute

Sunesis Presents Dose Escalation Results from the Phase 1A Healthy Volunteer Study Evaluating Oral Non-Covalent BTK inhibitor SNS-062

SOUTH SAN FRANCISCO, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced results from the Company’s Phase 1A study in healthy volunteers evaluating oral non-covalent BTK inhibitor SNS-062. The study demonstrated a favorable safety, pharmacokinetic (PK) and pharmacodynamic (PD) profile for SNS-062 in healthy subjects. The results were presented on Saturday, September 10th at the European School of Haematology’s (ESH) 2nd International Conference on New Concepts in B-Cell Malignancies at the Estoril Congress Centre in Estoril, Portugal. “Our first-in-human clinical results are encouraging and reinforce our belief that SNS-062 has the potential to become an important

Arcadis Finds New York City Earns Most Sustainable US City

HIGHLANDS RANCH, Colo., Sept. 12, 2016 (GLOBE NEWSWIRE) — New York City leads the United States for sustainability, according to the Sustainable Cities Index from Arcadis, the leading global design and consultancy for natural and built assets. From 22 North American cities measured, New York City ranks ahead of Boston (5th), San Francisco (6th) and Seattle (7th) while rounding out the bottom rankings are Indianapolis, Tampa and Detroit. Canadian cities ranked ahead of most U.S. cities, with Vancouver taking the highest spot and Toronto and Montreal ranking in the top five. With cities home to more than half the world’s

Cytokinetics Announces Additional Results From COSMIC-HF to Be Presented at the HFSA Annual Scientific Meeting

SOUTH SAN FRANCISCO, Calif., Sept. 09, 2016 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (Nasdaq:CYTK) announced today that additional results from COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure), a Phase 2 trial evaluating omecamtiv mecarbil in patients with chronic heart failure, will be presented in a Rapid Fire Abstract Session at the 20th Annual Heart Failure Society of America Scientific Meeting from September 17-20 in Orlando, FL. Abstract Title: The effect of omecamtiv mecarbil on symptoms of heart failure in the Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF)Speaker: John Teerlink,

Impac Mortgage Holdings, Inc. Announces Launch of Follow-on Public Offering

IRVINE, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) — Impac Mortgage Holdings, Inc. (NYSE MKT:IMH) (the “Company”) announced today that it has commenced an underwritten registered follow-on public offering of 2,500,000 shares of its common stock. In addition, the Company expects to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the follow-on public offering at the public offering price. JMP Securities LLC is acting as sole book-running manager for the offering. A registration statement relating to these securities was filed with the U.S. Securities and Exchange Commission